GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exelixis Inc (FRA:EX9) » Definitions » Shiller PE Ratio

Exelixis (FRA:EX9) Shiller PE Ratio : 48.08 (As of May. 17, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Exelixis Shiller PE Ratio?

As of today (2024-05-17), Exelixis's current share price is €19.23. Exelixis's E10 for the quarter that ended in Mar. 2024 was €0.40. Exelixis's Shiller PE Ratio for today is 48.08.

The historical rank and industry rank for Exelixis's Shiller PE Ratio or its related term are showing as below:

FRA:EX9' s Shiller PE Ratio Range Over the Past 10 Years
Min: 47.89   Med: 108.17   Max: 690.67
Current: 47.89

During the past years, Exelixis's highest Shiller PE Ratio was 690.67. The lowest was 47.89. And the median was 108.17.

FRA:EX9's Shiller PE Ratio is ranked worse than
65.33% of 150 companies
in the Biotechnology industry
Industry Median: 35.32 vs FRA:EX9: 47.89

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Exelixis's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.40 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Exelixis Shiller PE Ratio Historical Data

The historical data trend for Exelixis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exelixis Shiller PE Ratio Chart

Exelixis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 122.92 64.32

Exelixis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110.39 77.32 73.58 64.32 53.53

Competitive Comparison of Exelixis's Shiller PE Ratio

For the Biotechnology subindustry, Exelixis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exelixis's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exelixis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Exelixis's Shiller PE Ratio falls into.



Exelixis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Exelixis's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=19.23/0.4
=48.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exelixis's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Exelixis's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.11/131.7762*131.7762
=0.110

Current CPI (Mar. 2024) = 131.7762.

Exelixis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.280 100.560 -0.367
201409 -0.248 100.428 -0.325
201412 -0.243 99.070 -0.323
201503 -0.166 99.621 -0.220
201506 -0.196 100.684 -0.257
201509 -0.187 100.392 -0.245
201512 -0.174 99.792 -0.230
201603 -0.233 100.470 -0.306
201606 -0.134 101.688 -0.174
201609 -0.036 101.861 -0.047
201612 0.114 101.863 0.147
201703 0.047 102.862 0.060
201706 0.053 103.349 0.068
201709 0.218 104.136 0.276
201712 0.101 104.011 0.128
201803 0.300 105.290 0.375
201806 0.240 106.317 0.297
201809 0.351 106.507 0.434
201812 1.011 105.998 1.257
201903 0.212 107.251 0.260
201906 0.221 108.070 0.269
201909 0.281 108.329 0.342
201912 0.198 108.420 0.241
202003 0.136 108.902 0.165
202006 0.186 108.767 0.225
202009 -0.085 109.815 -0.102
202012 0.074 109.897 0.089
202103 0.004 111.754 0.005
202106 0.249 114.631 0.286
202109 0.102 115.734 0.116
202112 0.257 117.630 0.288
202203 0.191 121.301 0.207
202206 0.208 125.017 0.219
202209 0.232 125.227 0.244
202212 -0.085 125.222 -0.089
202303 0.112 127.348 0.116
202306 0.231 128.729 0.236
202309 0.003 129.860 0.003
202312 0.248 129.419 0.253
202403 0.110 131.776 0.110

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Exelixis  (FRA:EX9) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Exelixis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Exelixis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Exelixis (FRA:EX9) Business Description

Traded in Other Exchanges
Address
1851 Harbor Bay Parkway, Alameda, CA, USA, 94502
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis (FRA:EX9) Headlines

No Headlines